LGALS3BP is a potential target of antibody-drug conjugates in oral squamous cell carcinoma.
Cela I, Caponio VCA, Capone E, Pinti M, Mascitti M, Togni L, Lo Muzio L, Rubini C, De Laurenzi V, Lattanzio R, Perrotti V, Sala G.
Cela I, et al. Among authors: mascitti m.
Oral Dis. 2024 May;30(4):2039-2050. doi: 10.1111/odi.14719. Epub 2023 Aug 31.
Oral Dis. 2024.
PMID: 37649401